Previous 10 | Next 10 |
2024-03-22 15:00:00 ET More on the markets Wall Street Lunch: Fed Not Spooked By Recent Inflation SPY: Don't Fall For The Greed SPY: Assessing Economic Risks And Market Trends (Technical Analysis, Rating Downgrade) Investors sell $66B worth of money market fu...
2024-03-19 08:30:24 ET Whirlpool ( WHR ), Paramount Global ( PARA ) and Etsy ( ETSY ) were the most shorted companies among S&P 500 stocks in February ( ranked by short interest as a percentage of shares float ).... Read the full article on Seeking Alpha For ...
2024-03-18 20:06:34 ET Summary Coatue Management's 13F portfolio value increased from $19.71B to $23.84B in the last quarter. The largest five stakes in the portfolio are Nvidia, Meta Platforms, Advanced Micro Devices, Amazon.com, and Microsoft. New stakes include Salesforce a...
2024-03-15 12:39:32 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Now might be a great time for investors to consider investing in precision medicine stocks. For those who don’t know, precision medicine is an approach to disease treatment and preventio...
2024-03-15 09:29:14 ET Short interest in healthcare stocks moved higher from end of January to end of February, with bets against healthcare provider and services still being the most shorted sub-sector and Moderna jumping to be the most shorted company.... Read the full article on Se...
2024-03-14 07:20:30 ET More on WuXi AppTec, WuXi AppTec, etc. Potential U.S. Targeting Casts Shadow Over WuXi AppTec Family WuXi Biologics: Recent Share Price Recovery Isn't Sustainable Historical earnings data for WuXi AppTec Dividend scorecard for WuXi AppT...
2024-03-12 20:45:07 ET Moderna, Inc. (MRNA) Barclays 26th Annual Global Healthcare Conference Call March 12, 2024 14:35 ET Company Participants Lavina Talukdar - Senior Vice President and Head, Investor Relations Conference Call Participants Gena Wang - Barcl...
2024-03-11 08:53:00 ET It's always possible to come up with a justification for why someone should sell their shares of a stock, but that doesn't make every justification correct. For a company like Moderna (NASDAQ: MRNA) that just reported some not-so-great news, rushing to quit yo...
2024-03-09 19:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-07 13:29:15 ET More on AstraZeneca, CSL, etc. Sanofi (SNY) TD Cowen 44th Annual Health Care Conference (Transcript) GSK Plc: An Undervalued Vaccine Behemoth That Is Resuming Growth; Buy CSL Limited: Earnings Beat Doesn't Mask Unfavorable Trial Results (Downgr...
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, MA / ACCESSWIRE / July 10, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, August 1, 2024 to report its second quarter 2024 financial results, and provide a corporate update. A live webcast of the c...
CAMBRIDGE, MA AND OSAKA, JAPAN / ACCESSWIRE / July 8, 2024 / Moderna, Inc. (Nasdaq:MRNA) and Mitsubishi Tanabe Pharma Corporation today announced that the companies have entered into a joint agreement regarding the co-promotion of Moderna's mRNA respiratory vaccine portfolio in Japan, including ...
CAMBRIDGE, MA / ACCESSWIRE / July 2, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced a project award of $176 million through the Rapid Response Partnership Vehicle (RRPV) to accelerate the development of mRNA-based pandemic influenza vaccines. The RRPV is a Consortium funded by the Biomedical...